| 1 |
Causality, Severity, and Avoidability of Adverse Drug Reactions in Hospitalized Children: A Prospective Cohort Study |
|
| | Saurabh Gupta, Syed A Zaki, Sanjeevani Masavkar, Preeti Shanbag | | | Cureus. 2023; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Antiseizure Drugs and Movement Disorders |
|
| | Michel Sáenz-Farret, Marina A. J. Tijssen, Dawn Eliashiv, Robert S. Fisher, Kapil Sethi, Alfonso Fasano | | | CNS Drugs. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Movement disorders associated with antiseizure medications: A systematic review |
|
| | Daniel J. Zhou, Spriha Pavuluri, Isha Snehal, Cynthia M. Schmidt, Miguel Situ-Kcomt, Olga Taraschenko | | | Epilepsy & Behavior. 2022; 131: 108693 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Carbamazepine-, Oxcarbazepine-, Eslicarbazepine-Associated Movement Disorder: A Literature Review |
|
| | Jamir Pitton Rissardo, Ana Letícia Fornari Caprara | | | Clinical Neuropharmacology. 2020; 43(3): 66 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Drug-induced dystonia |
|
| | T. M. Ostroumova, V. A. Tolmacheva, O. D. Ostroumova, V. A. Parfenov | | | Neurology, Neuropsychiatry, Psychosomatics. 2020; 12(5): 4 | | | [Pubmed] [Google Scholar] [DOI] | |
|
